The novel treatment of the medication represents a exciting breakthrough in the handling of the condition. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide163765.bloggerswise.com/50489473/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment